Fusion gene information | Fusion gene name: DNMT1-SNX13 |
Fusion gene ID: hg1786tg23161 | | Hgene | Tgene | Gene symbol | DNMT1 | SNX13 | Gene ID | 1786 | 23161 | Gene name | DNA methyltransferase 1 | sorting nexin 13 |
Synonyms | ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT|m.HsaI | RGS-PX1 |
Cytomap | ('DNMT1')('SNX13') 19p13.2 | 7p21.1 |
Type of gene | protein-coding | protein-coding |
Description | DNA (cytosine-5)-methyltransferase 1CXXC-type zinc finger protein 9DNA (cytosine-5-)-methyltransferase 1DNA MTase HsaIDNA methyltransferase HsaI | sorting nexin-13rgs domain- and phox domain-containing protein |
Modification date | 20200313 | 20200313 |
UniProtAcc | . | . |
Ensembl transtripts involved in fusion gene | ENST00000340748, ENST00000359526, ENST00000540357, ENST00000589538,
| |
Fusion gene scores | * DoF score | 14 X 12 X 11=1848 | 5 X 5 X 4=100 |
# samples | 17 | 6 |
** MAII score | log2(17/1848*10)=-3.44235810527836 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/100*10)=-0.736965594166206 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 |
Context | PubMed: DNMT1 [Title/Abstract] AND SNX13 [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | DNMT1(10313999)-SNX13(17889538), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | DNMT1 | C3807295 | CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT | 11 | CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | DNMT1 | C3279885 | Hereditary Sensory and Autonomic Neuropathy Type Ie | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | DNMT1 | C0036341 | Schizophrenia | 4 | PSYGENET |
Hgene | DNMT1 | C0005586 | Bipolar Disorder | 2 | PSYGENET |
Hgene | DNMT1 | C0006142 | Malignant neoplasm of breast | 2 | CTD_human |
Hgene | DNMT1 | C0024623 | Malignant neoplasm of stomach | 2 | CTD_human |
Hgene | DNMT1 | C0038356 | Stomach Neoplasms | 2 | CTD_human |
Hgene | DNMT1 | C0678222 | Breast Carcinoma | 2 | CTD_human |
Hgene | DNMT1 | C1257931 | Mammary Neoplasms, Human | 2 | CTD_human |
Hgene | DNMT1 | C1384666 | hearing impairment | 2 | CTD_human;GENOMICS_ENGLAND |
Hgene | DNMT1 | C1458155 | Mammary Neoplasms | 2 | CTD_human |
Hgene | DNMT1 | C1708349 | Hereditary Diffuse Gastric Cancer | 2 | CTD_human |
Hgene | DNMT1 | C4704874 | Mammary Carcinoma, Human | 2 | CTD_human |
Hgene | DNMT1 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | DNMT1 | C0003469 | Anxiety Disorders | 1 | CTD_human |
Hgene | DNMT1 | C0003865 | Arthritis, Adjuvant-Induced | 1 | CTD_human |
Hgene | DNMT1 | C0004096 | Asthma | 1 | CTD_human |
Hgene | DNMT1 | C0007097 | Carcinoma | 1 | CTD_human |
Hgene | DNMT1 | C0007102 | Malignant tumor of colon | 1 | CTD_human |
Hgene | DNMT1 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Hgene | DNMT1 | C0020071 | Hereditary Sensory Autonomic Neuropathy, Type 1 | 1 | CTD_human |
Hgene | DNMT1 | C0020072 | Hereditary Sensory Autonomic Neuropathy, Type 2 | 1 | CTD_human |
Hgene | DNMT1 | C0020074 | HSAN Type IV | 1 | CTD_human |
Hgene | DNMT1 | C0020075 | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1 | CTD_human |
Hgene | DNMT1 | C0025149 | Medulloblastoma | 1 | CTD_human |
Hgene | DNMT1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | DNMT1 | C0027889 | Hereditary Sensory and Autonomic Neuropathies | 1 | CTD_human |
Hgene | DNMT1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | DNMT1 | C0086405 | Hereditary Sensory Radicular Neuropathy | 1 | CTD_human |
Hgene | DNMT1 | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
Hgene | DNMT1 | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
Hgene | DNMT1 | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
Hgene | DNMT1 | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
Hgene | DNMT1 | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
Hgene | DNMT1 | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
Hgene | DNMT1 | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
Hgene | DNMT1 | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
Hgene | DNMT1 | C0205699 | Carcinomatosis | 1 | CTD_human |
Hgene | DNMT1 | C0205833 | Medullomyoblastoma | 1 | CTD_human |
Hgene | DNMT1 | C0278510 | Childhood Medulloblastoma | 1 | CTD_human |
Hgene | DNMT1 | C0278876 | Adult Medulloblastoma | 1 | CTD_human |
Hgene | DNMT1 | C0282612 | Prostatic Intraepithelial Neoplasias | 1 | CTD_human |
Hgene | DNMT1 | C0338630 | Senile Paranoid Dementia | 1 | CTD_human |
Hgene | DNMT1 | C0376280 | Anxiety States, Neurotic | 1 | CTD_human |
Hgene | DNMT1 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Hgene | DNMT1 | C0497327 | Dementia | 1 | CTD_human |
Hgene | DNMT1 | C0525045 | Mood Disorders | 1 | PSYGENET |
Hgene | DNMT1 | C0699739 | Sensory Neuropathy, Hereditary | 1 | CTD_human |
Hgene | DNMT1 | C0751071 | Familial Dementia | 1 | CTD_human |
Hgene | DNMT1 | C0751291 | Desmoplastic Medulloblastoma | 1 | CTD_human |
Hgene | DNMT1 | C0887833 | Carcinoma, Pancreatic Ductal | 1 | CTD_human |
Hgene | DNMT1 | C0971858 | Arthritis, Collagen-Induced | 1 | CTD_human |
Hgene | DNMT1 | C0993582 | Arthritis, Experimental | 1 | CTD_human |
Hgene | DNMT1 | C1275668 | Melanotic medulloblastoma | 1 | CTD_human |
Hgene | DNMT1 | C1279420 | Anxiety neurosis (finding) | 1 | CTD_human |
Hgene | DNMT1 | C2931852 | Clear-cell metastatic renal cell carcinoma | 1 | CTD_human |